Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Theravance Biopharma, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of TBPH: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1693173+7
Shares49.6M2.42M50.2M+2.99M (+6.3%)
Value$927.2M$45.3M$814.2M−$67.7M (−7.7%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to TBPH in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC1,783,753$29.0M0.00%
Vanguard Portfolio Management LLC400,759$6.50M0.00%
Vanguard Fiduciary Trust Co262,073$4.25M0.00%
683 Capital Management, LLC250,000$4.06M0.38%
Caption Management, LLC163,704$2.66M0.13%
Renaissance Technologies LLC127,916$2.08M0.00%
Jackson Creek Investment Advisors LLC118,560$1.92M0.57%
Verition Fund Management LLC110,000$1.79M0.02%
Rangeley Capital, LLC103,000$1.67M1.81%
CWA Asset Management Group, LLC94,902$1.54M0.05%
Marble Bar Asset Management LLP85,074$1.38M1.36%
Swiss National Bank75,100$1.22M0.00%
Virginia Retirement Systems Et Al64,700$1.05M0.01%
Precision Wealth Strategies, LLC62,815$1.02M0.34%
Empowered Funds, LLC55,463$900.2K0.01%
Principal Financial Group Inc52,264$848.2K0.00%
Aquatic Capital Management LLC32,599$529.1K0.02%
Woodline Partners LP30,122$488.9K0.00%
DRW Securities, LLC28,304$459.4K0.03%
Freestone Grove Partners LP26,647$432.5K0.00%
Vanguard Asset Management, Ltd25,612$415.7K0.00%
Prelude Capital Management, LLC25,000$405.8K0.03%
Voya Investment Management LLC19,484$316.2K0.00%
Vanguard Global Advisers, LLC17,845$289.6K0.00%
Financiere des Professionnels - Fonds d,investissement inc.16,523$268.2K0.02%
Cannon Global Investment Management, LLC16,047$260.4K0.63%
State of New Jersey Common Pension Fund D12,988$210.8K0.00%
Mercer Global Advisors Inc12,617$204.8K0.00%
Vanguard Investments Australia, Ltd.11,791$191.4K0.00%
Profund Advisors LLC11,236$182.4K0.01%
Allspring Global Investments Holdings, LLC10,783$170.8K0.00%
Globeflex Capital L P10,512$170.6K0.03%
Headlands Technologies LLC10,471$169.9K0.02%
Arizona State Retirement System10,438$169.4K0.00%
Brinker Capital Investments, LLC10,243$166.2K0.00%
KLP Kapitalforvaltning AS8,400$136.3K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.1,136$18.4K0.00%
Stone House Investment Management, LLC240$3.90K0.00%
Financial Network Wealth Advisors LLC31$5030.00%
Basecamp Wealth Advisors LLC29$4710.00%
Zions Bancorporation, National Association15$2430.00%

Sold out (34)

Institutions that held Theravance Biopharma, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (3)

Institutions that held Theravance Biopharma, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc2,367,353$44.3M
Militia Capital Partners, LP54,200$1.01M
Global Retirement Partners, LLC300$5.61K